MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202637073414 A) filed by Ti. Farma Srl on June 12, 2026, for Cyclic Iron (ii) Citrate Monohydrate And Production Method Thereof, Pharmaceutical And/Or Nutraceutical And/Or Food Compositions Comprising It And Uses Thereof In Therapy And In The Nutritional Field.
Inventors include Polcaro, Fabio; Savastano, Alessandro; Polcaro, Alessio; and Polcaro, Filippo.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: In an iron (II) citrate monohydrate, identified by the formula FeC6H6O7-H2O ( Ferrous citrate monohydrate or iron citrate (II) monohydrate), obtained according to a particular production method, citric acid and elemental iron are bound in a molecular complex where the iron is agglomerated in the citrate which moves to a cyclic form and the iron is bound to the O groups of the carboxylic groups 1 and 3 through ionic bonds, forming two enantiomers, D and L (R and S), both perfectly water- soluble and highly assimilable by the human body. Formula (L) & Formula (D). With a different absorption mechanism from traditional iron molecules, said iron citrate monohydrate is usable in pharmaceutical and/ or nutraceutical and/ or food compositions, in particular in the treatment and prevention of iron deficiency anemias and in general of all diseases and disorders associated with iron deficiency. The effectiveness is proven by several examples.
Disclaimer: Curated by HT Syndication.
